Veillette, H. (2023) “In Brief: Laboratory and clinical monitoring requirements for JAK inhibitors”, Canadian Dermatology Today. Toronto, Canada, 4(1), pp. 20–22. Available at: https://canadiandermatologytoday.com/article/view/4-1-veillette (Accessed: 23 November 2024).